October 25, 2016 6:34 AM ET


Company Overview of miRagen Therapeutics, Inc.

Key Executives for miRagen Therapeutics, Inc.

NameBoard RelationshipsTitleAge
William S. Marshall Ph.D.35 RelationshipsCo-Founder, Chief Executive Officer, President and Director--
Bruce L. Booth D.Phil., Ph.D.116 RelationshipsCo-Founder and Chairman of The Board 42
Michael R. Bristow M.D., Ph.D.18 RelationshipsCo-Founder and Member of the Scientific Advisory Board71
Marvin H. Caruthers Ph.D.49 RelationshipsCo-Founder and Member of Scientific Advisory Board76
Eric N. Olson Ph.D.63 RelationshipsCo-Founder and Member of Scientific Advisory Board--
View More Key Executives

miRagen Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bruce L. Booth D.Phil., Ph.D. 116 RelationshipsmiRagen Therapeutics, Inc.42
William S. Marshall Ph.D. 35 RelationshipsmiRagen Therapeutics, Inc.--
Eric N. Olson Ph.D. 63 RelationshipsmiRagen Therapeutics, Inc.--
Michael R. Bristow M.D., Ph.D. 18 RelationshipsARCA biopharma, Inc.71
Marvin H. Caruthers Ph.D. 49 RelationshipsmiRagen Therapeutics, Inc.76
View All Board Members

miRagen Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
miRagen Therapeutics, Inc. CEO Compensation
Industry Average


Benitec Biopharma Limited to Appoint Jerel A. Banks to the Board
October 23, 2016 11:06 PM ET
Nordic Nanovector ASA Announces Board Changes
October 22, 2016 7:48 PM ET
4SC AG Announces Executive Changes
October 21, 2016 9:18 AM ET
Rosetta Genomics Ltd. Appoints Mark R. Willig as Chief Commercial Officer
October 20, 2016 12:40 PM ET
ChemoCentryx Appoints Henry A. McKinnell, Jr. to Board of Directors
October 20, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact miRagen Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.